PT  - JOURNAL ARTICLE
AU  - Oleg Volkov
AU  - Svetlana Borozdenkova
AU  - Alexander Gray
TI  - Prediction of Covid-19 vaccine effectiveness in adult populations and in clinically-vulnerable subgroups
AID  - 10.1101/2022.11.22.22282637
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.11.22.22282637
4099  - http://medrxiv.org/content/early/2022/11/25/2022.11.22.22282637.short
4100  - http://medrxiv.org/content/early/2022/11/25/2022.11.22.22282637.full
AB  - Predictions of Covid vaccine effectiveness could support rapid and effective measures against the pandemic. Our modelling boosts the accuracy and applications of these predictions, especially to subgroups. We model the symptomatic effectiveness of Comirnaty or Vaxzevria with 50% neutralising antibody titres from a large UK immunogenicity study and with up to 68 effectiveness estimates from 23 vaccine studies. We predicted effectiveness in adult populations, age and disease subgroups, with 45% (95% CI: 27–63) predicted against Omicron BA.1 for Comirnaty boosters in haemodialysis patients. Prediction errors for two Comirnaty doses in adults were 1.9%, 2.6% and 0.4%, against the Alpha, Beta and Delta variants, versus 3.6%, 28% and 8.7% with a state-of-the-art alternative; and for Vaxzevria, 1.1% and 0.7% against Alpha and Delta, versus 18% and 20.4%. Identical titres implied between 18% (95% CI: 1–33) and 31% (95% CI: 13–50) lower Comirnaty effectiveness against Omicron BA.1 than Delta.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study used ONLY openly available human data that were originally located at: https://github.com/davidlvb/Crick-UCLH-Legacy-AZ-VOCs-2021-06 https://github.com/davidlvb/Crick-UCLH-Legacy-Omicron-2021-12 https://github.com/EdjCarr/Crick-HD-AZD-BNT-VOCs-2021-07 https://github.com/EdjCarr/Crick-HD-Omicron-2021-12I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used for the paper are publically available online. https://github.com/XitificOS/prediction_Covid_VE